Nike stock slips as investors brace for earnings and a slower turnaround

Web Desk June 30, 2026

0 4 3 minutes read

Nike stock slips as investors brace for earnings and a slower turnaround

NIKE, Inc. (NKE) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to investor caution ahead of Nike’s June 30 fiscal fourth-quarter earnings release and lingering concern that its turnaround is taking longer than hoped. Recent analyst downgrades have added pressure by highlighting weaker-than-expected progress in Greater China and Europe, as well as uncertainty tied to a finance leadership change.

Details:

Nike scheduled its Q4 FY26 earnings release and earnings call for June 30, putting the stock under a microscope as investors looked for proof that demand and margins are stabilizing.

At its prior quarterly update, management pointed to improving wholesale momentum in North America, but the broader recovery remained uneven across regions and channels.

A late-June analyst downgrade cited a slower turnaround, softer trends in Greater China and EMEA, and the risk that marketplace cleanup takes longer than expected.

The same note also flagged Nike’s upcoming CFO transition as another factor that could delay a fuller strategic reset and keep near-term expectations restrained.

Sources:

Nike Investor Relations, StreetInsider, Reuters

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$NKE Insider Trading Activity

$NKE insiders have traded $NKE stock on the open market 6 times in the past 6 months. Of those trades, 4 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $NKE stock by insiders over the last 6 months:

TIMOTHY D COOK purchased 25,000 shares for an estimated $1,060,750
ELLIOTT HILL (PRESIDENT & CEO) purchased 23,660 shares for an estimated $999,999
PHILIP MCCARTNEY (EVP: CHIEF INN,PROD&DSG OFCR) sold 17,398 shares for an estimated $803,439
ROBERT LEINWAND (EVP: Chief Legal Officer) sold 9,065 shares for an estimated $565,021
ROBERT HOLMES SWAN purchased 11,781 shares for an estimated $500,002
JOHN W JR ROGERS purchased 4,000 shares for an estimated $173,360

To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive NKE Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$NKE Hedge Fund Activity

We have seen 827 institutional investors add shares of $NKE stock to their portfolio, and 1,261 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP removed 47,283,318 shares (-98.4%) from their portfolio in Q1 2026, for an estimated $2,463,697,284
JENNISON ASSOCIATES LLC removed 11,838,528 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $754,232,618
VIKING GLOBAL INVESTORS LP removed 8,996,579 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $573,172,048
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 6,998,203 shares (-94.2%) from their portfolio in Q1 2026, for an estimated $364,641,367
JPMORGAN CHASE & CO added 6,790,140 shares (+43.2%) to their portfolio in Q4 2025, for an estimated $432,599,819
WELLINGTON MANAGEMENT GROUP LLP added 6,579,523 shares (+20.7%) to their portfolio in Q1 2026, for an estimated $342,826,045
FUNDSMITH LLP removed 5,770,181 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $300,655,281

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$NKE Congressional Stock Trading

Members of Congress have traded $NKE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NKE stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative’s congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$NKE Analyst Ratings

Wall Street analysts have issued reports on $NKE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a “Outperform” rating on 01/06/2026

To track analyst ratings and price targets for $NKE, check out Quiver Quantitative’s $NKE forecast page.

$NKE Price Targets

Multiple analysts have issued price targets for $NKE recently. We have seen 19 analysts offer price targets for $NKE in the last 6 months, with a median target of $50.0.

Here are some recent targets:

Matthew Boss from JP Morgan set a target price of $47.0 on 06/29/2026
Krisztina Katai from Deutsche Bank set a target price of $43.0 on 06/26/2026
Brian Nagel from Oppenheimer set a target price of $60.0 on 06/26/2026
Robert Drbul from BTIG set a target price of $55.0 on 06/25/2026
Laurent Vasilescu from BNP Paribas set a target price of $23.0 on 06/23/2026
Michael Binetti from Evercore ISI Group set a target price of $46.0 on 06/23/2026
Brooke Roach from Goldman Sachs set a target price of $46.0 on 06/23/2026

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.